Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Omeros Corporation (OMER)

17.07 -0.48 (-2.74%)
As of 11:47:34 AM EST. Market Open.
Trade Omeros on Coinbase

News headlines

Updated 16m ago
Powered by Yahoo Scout

Omeros faces a second European regulatory setback for narsoplimab, while its U.S. launch of YARTEMLEA continues generating commercial revenue. The company’s investment case now depends heavily on U.S. adoption, additional clinical indications, and its ability to fund development with available cash and operating proceeds.

Mobilize your Website
View Site in Mobile | Classic
Share by: